These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


299 related items for PubMed ID: 10194148

  • 1. Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge.
    Scheerens H, Buckley TL, Muis TL, Garssen J, Dormans J, Nijkamp FP, Van Loveren H.
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1074-80. PubMed ID: 10194148
    [Abstract] [Full Text] [Related]

  • 2. Toluene diisocyanate-induced in vitro tracheal hyperreactivity in the mouse.
    Scheerens H, Buckley TL, Davidse EM, Garssen J, Nijkamp FP, Van Loveren H.
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):858-65. PubMed ID: 8887575
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma.
    Matheson JM, Johnson VJ, Vallyathan V, Luster MI.
    Toxicol Sci; 2005 Mar; 84(1):88-98. PubMed ID: 15590891
    [Abstract] [Full Text] [Related]

  • 5. TDI can induce respiratory allergy with Th2-dominated response in mice.
    Ban M, Morel G, Langonné I, Huguet N, Pépin E, Binet S.
    Toxicology; 2006 Jan 20; 218(1):39-47. PubMed ID: 16271432
    [Abstract] [Full Text] [Related]

  • 6. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.
    Johnson VJ, Yucesoy B, Luster MI.
    J Allergy Clin Immunol; 2005 Oct 20; 116(4):851-8. PubMed ID: 16210060
    [Abstract] [Full Text] [Related]

  • 7. Dermal exposure determines the outcome of repeated airway exposure in a long-term chemical-induced asthma-like mouse model.
    Pollaris L, Van Den Broucke S, Decaesteker T, Cremer J, Seys S, Devos FC, Provoost S, Maes T, Verbeken E, Vande Velde G, Nemery B, Hoet PHM, Vanoirbeek JAJ.
    Toxicology; 2019 Jun 01; 421():84-92. PubMed ID: 31071364
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge.
    Karol MH, Tollerud DJ, Campbell TP, Fabbri L, Maestrelli P, Saetta M, Mapp CE.
    Am J Respir Crit Care Med; 1994 Mar 01; 149(3 Pt 1):611-5. PubMed ID: 8118626
    [Abstract] [Full Text] [Related]

  • 9. Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice.
    Vanoirbeek JA, Tarkowski M, Ceuppens JL, Verbeken EK, Nemery B, Hoet PH.
    Toxicol Sci; 2004 Aug 01; 80(2):310-21. PubMed ID: 15129019
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma.
    De Vooght V, Vanoirbeek JA, Haenen S, Verbeken E, Nemery B, Hoet PH.
    Toxicology; 2009 May 02; 259(1-2):84-9. PubMed ID: 19428947
    [Abstract] [Full Text] [Related]

  • 12. Multiple challenges in a mouse model of chemical-induced asthma lead to tolerance: ventilatory and inflammatory responses are blunted, immunologic humoral responses are not.
    Vanoirbeek JA, De Vooght V, Nemery B, Hoet PH.
    Toxicology; 2009 Mar 29; 257(3):144-52. PubMed ID: 19150644
    [Abstract] [Full Text] [Related]

  • 13. Is toluene diamine a sensitizer and is there cross-reactivity between toluene diamine and toluene diisocyanate?
    Vanoirbeek JA, De Vooght V, Synhaeve N, Nemery B, Hoet PH.
    Toxicol Sci; 2009 Jun 29; 109(2):256-64. PubMed ID: 19332649
    [Abstract] [Full Text] [Related]

  • 14. Rats repeatedly exposed to toluene diisocyanate exhibit immune reactivity against methyl isocyanate-protein conjugates.
    Svensson-Elfsmark L, Koch BL, Gustafsson A, Bucht A.
    Int Arch Allergy Immunol; 2009 Jun 29; 150(3):229-36. PubMed ID: 19494520
    [Abstract] [Full Text] [Related]

  • 15. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate.
    Matheson JM, Johnson VJ, Luster MI.
    Toxicol Sci; 2005 Mar 29; 84(1):99-109. PubMed ID: 15590890
    [Abstract] [Full Text] [Related]

  • 16. Glutathione-conjugated toluene diisocyanate causes airway inflammation in sensitised mice.
    Valstar DL, Schijf MA, Nijkamp FP, Bloksma N, Henricks PA.
    Arch Toxicol; 2004 Sep 29; 78(9):533-9. PubMed ID: 15340776
    [Abstract] [Full Text] [Related]

  • 17. Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI).
    Matheson JM, Lange RW, Lemus R, Karol MH, Luster MI.
    Clin Exp Allergy; 2001 Jul 29; 31(7):1067-76. PubMed ID: 11467998
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure.
    Park HS, Nahm DH.
    Clin Exp Allergy; 1997 Oct 29; 27(10):1145-50. PubMed ID: 9383254
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Airway hyperreactivity elicited by toluene diisocyanate (TDI)-albumin conjugate is not accompanied by airway eosinophilic infiltration in guinea pigs.
    Huang J, Millecchia LL, Frazer DG, Fedan JS.
    Arch Toxicol; 1998 Feb 29; 72(3):141-6. PubMed ID: 9520137
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.